skip to Main Content

Identification of a Six-miRNA Panel in Serum Benefiting Pancreatic Cancer Diagnosis

Newsfeed image, light gray text on dark gray background
Pancreatic cancer (PC) has posed a great health threat to a growing number of people all over the world. Detection of serum miRNAs, being sensitive, noninvasive, and easy to obtain, has a great potential of being a novel screening method for PC patients.

In this study, we investigated miRNA expression levels in serum by qRT‐PCR. The study was divided into four phases: the screening, training, testing, and external validation stage. We firstly chose candidate miRNAs using Exiqon panels in the screening phase. Read more . . .

Back To Top